CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 


<
Alexion Pharmaceuticals Inc  (ALXN)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Alexion Pharmaceuticals Inc

ALXN's Financial Statements and Analysis






Alexion Pharmaceuticals Inc reported in IV. Quarter net earnings per share of $0.13 a decrease by 0 % year on year from $0.41 and decline of 0 % from $0.35 earned in III. Quarter (Sep 30 2017).

Alexion Pharmaceuticals Inc's Revenue rose by % in IV. Quarter (Dec 31 2017) year on year, to $910 million and advanced by 5.9 % sequentially.


Alexion Pharmaceuticals Inc is
More on ALXN's Income Statement

IV. Quarter
Earnings Per Share Revenues
$ 0.13 $  910 Mill
$-0.28     -68.29 % $+79M     +9.47 %
You need to upgrade your Flash Player
ALXN's NET INCOME

Alexion Pharmaceuticals Inc's net income of $30 million in IV. Quarter decreased by -68.94 % from net earnings of $98 million achieved in IV. Quarter a year ago.

Sequentially net earnings fell by -61.15 % from net income of $78.00 million realized in previous quarter.

More on ALXN's Growth

Inventories Inventories grew by 22.77 % to $460 million from IV. Quarter a year ago, sequentially inventories rose by 4.4 %. ALXN's Cash flow In IV. Quarter company's net cash flow was $34 million, capital expenditures grew by -17.48%, to $-88 millions compare to same quarter a year ago and rose by -6.06% from III. Quarter (Sep 30 2017).

More on ALXN's Cash flow Statement



Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 4.95 cash per share, on a free-cash flow basis 252.3 % of net earning per share.

Book value fell by -0.83 % sequentially to $39.42 per share.
Tangible Book value grew to $ -0.44 per share from $ -0.56.

Company issued 0.60 million shares or 0.27 % in IV. Quarter.
Interest Coverage Ratio was 6.57. Debt Coverage Ratio was 0.22.

More on ALXN's Dividends
 Market Capitalization (Millions) 24,326
 Shares Outstanding (Millions) 226
 Total Debt (Millions $) 2,888
 Revenue (TTM) (Millions $) 3,551
 Net Income (TTM) (Millions $) 443
 Cash Flow (TTM) (Millions $) -382
 Capital Exp. (TTM) (Millions $) -357
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273





Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 4.95 cash per share, on a free-cash flow basis 252.3 % of net earning per share.

Book value fell by -0.83 % sequentially to $39.42 per share.
Tangible Book value grew to $ -0.44 per share from $ -0.56.

Company issued 0.60 million shares or 0.27 % in IV. Quarter.
Interest Coverage Ratio was 6.57. Debt Coverage Ratio was 0.22.

More on ALXN's Dividends
 Market Capitalization (Millions) 24,326
 Shares Outstanding (Millions) 226
 Total Debt (Millions $) 2,888
 Revenue (TTM) (Millions $) 3,551
 Net Income (TTM) (Millions $) 443
 Cash Flow (TTM) (Millions $) -382
 Capital Exp. (TTM) (Millions $) -357
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PAYM's Profile

Stock Price

PAYM's Financials

Business Description

Fundamentals

Charts & Quotes

PAYM's News

Suppliers

PAYM's Competitors

Customers & Markets

Economic Indicators

PAYM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071